+1 888-880-9539Search News by Tag: immunotherapy
73 news stories found
Press Release
September 9, 2026
Tumor microenvironment drives natural killer cell diversity, reshaping cancer immunotherapy landscape
Read Press Release
Press Release
August 25, 2026
Creative Biolabs will host a live webinar, "Modeling T Cell Dysfunction in Tumor Microenvironments," on September 1, 2026, at 10:00 AM EDT.
Read Press Release
Press Release
August 8, 2026
Risk-guided care reshapes childhood neuroblastoma treatment
Read Press Release
Press Release
July 12, 2026
Beyond High-dose IL-2: A novelTIL expansion platform improves safety and efficacyof TIL therapyina preclinical study
Read Press Release
Press Release
July 12, 2026
Decoding the cancer-immunity cycle: A New roadmap for breast cancer immunotherapy
Read Press Release
Press Release
July 11, 2026
Microbiome and cancer: From passive bystanders to active players
Read Press Release
Press Release
June 6, 2026
Smart nanoparticles turn 'cold' tumors hot: A new era in cancer immunotherapy
Read Press Release
Press Release
May 30, 2026
The Humanized Mouse Platform of Alfa Cytology Facilitates Preclinical Studies of Immunotherapy Drugs
Alfa Cytology offers huPBMC and huHSC humanized mouse models and in vivo immunotherapy testing for preclinical immunotherapy drug research.
Read Press Release
Press Release
May 26, 2026
Creative Biolabs introduces custom cell-based artificial T-cell stimulator development services, featuring antigen-specific CD4+ and CD8+ platforms, to accelerate CAR-T and TIL cell therapy research and streamline in vitro immunotherapy evaluation.
Read Press Release
Press Release
May 25, 2026
In response to growing demand for integrated mRNA research solutions, Creative Biolabs provides a broad portfolio of services and products designed to support early-stage and translational mRNA immunotherapy programs.
Read Press Release
Press Release
May 22, 2026
Creative Biolabs, a leading biotechnology CRO, has expanded its complement therapeutics and macrophage research solutions to support advanced immunology studies.
Read Press Release
Press Release
April 25, 2026
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Read Press Release
Press Release
April 25, 2026
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.
Read Press Release
Press Release
April 24, 2026
Targeting glutamine metabolism to enhance CAR-macrophage efficacy in solid tumors
Read Press Release
Press Release
April 22, 2026
Creative Biolabs, a global leader in antibody engineering, has announced the expansion of its integrated suite of solutions focused on antibody-dependent cellular cytotoxicity (ADCC).
Read Press Release
Press Release
April 18, 2026
Breast cancer special issue spotlights AI while widening the view of precision care
Read Press Release
Press Release
March 31, 2026
Alfa Cytology provides in vivo research support for tumor studies and immunotherapy using cancer animal models and humanized immune system mice.
Read Press Release
Press Release
January 8, 2026
Alfa Cytology provides in vitro and in vivo models of cancer and Next-Gen PBMC humanized PDX platform for tumor research and immuno-oncology studies.
Read Press Release
Press Release
November 25, 2025
Creative Biolabs launches a comprehensive CDMO solutions to match the exact needs of CAR-T cell therapies.
Read Press Release